Last reviewed · How we verify
ropivicaine 0.2% — Competitive Intelligence Brief
marketed
Local anesthetic (amide)
Voltage-gated sodium channels
Anesthesia
Small molecule
Live · refreshed every 30 min
Target snapshot
ropivicaine 0.2% (ropivicaine 0.2%) — University of Alabama at Birmingham. Ropivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| ropivicaine 0.2% TARGET | ropivicaine 0.2% | University of Alabama at Birmingham | marketed | Local anesthetic (amide) | Voltage-gated sodium channels | |
| Lidocaine solution ("A") | Lidocaine solution ("A") | Hospital Universitari de Bellvitge | marketed | Local anesthetic | Voltage-gated sodium channels | |
| Propofol/Lidocaine | Propofol/Lidocaine | NYU Langone Health | marketed | Intravenous anesthetic combination | GABA-A receptor (propofol); voltage-gated sodium channels (lidocaine) | |
| lamotrigine (generic Teva) | lamotrigine (generic Teva) | University of Maryland, Baltimore | marketed | Anticonvulsant / Mood stabilizer | Voltage-gated sodium channels; glutamate release inhibition | |
| Lidocaine (drug) | Lidocaine (drug) | Daniel A Tonetti, MD | marketed | Local anesthetic | Voltage-gated sodium channels | |
| Bupivacaine Liposomes(BL) | Bupivacaine Liposomes(BL) | Huazhong University of Science and Technology | marketed | Local anesthetic (liposomal formulation) | Voltage-gated sodium channels | |
| Lidocaine gel 2% | Lidocaine gel 2% | Atlantic Health System | marketed | Local anesthetic | Voltage-gated sodium channels |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Local anesthetic (amide) class)
- Poznan University of Medical Sciences · 4 drugs in this class
- Nantes University Hospital · 3 drugs in this class
- Bozyaka Training and Research Hospital · 2 drugs in this class
- ASST Gaetano Pini-CTO · 2 drugs in this class
- Centre Hospitalier Universitaire de Nīmes · 1 drug in this class
- Chiang Mai University · 1 drug in this class
- Beijing Tiantan Hospital · 1 drug in this class
- Complejo Hospitalario Universitario de Granada · 1 drug in this class
- Ciusss de L'Est de l'Île de Montréal · 1 drug in this class
- China Medical University, China · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- ropivicaine 0.2% CI watch — RSS
- ropivicaine 0.2% CI watch — Atom
- ropivicaine 0.2% CI watch — JSON
- ropivicaine 0.2% alone — RSS
- Whole Local anesthetic (amide) class — RSS
Cite this brief
Drug Landscape (2026). ropivicaine 0.2% — Competitive Intelligence Brief. https://druglandscape.com/ci/ropivicaine-0-2. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab